◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › AZTA

Azenta Inc (AZTA) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-16

Azenta Inc (AZTA) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Burlington, United States with about 2,900 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-09-30, AZTA reported $594M in revenue and ($56M) in net income.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments.

Interactive charts & full statements → Open the AZTA valuation workbench →

AZTA Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Revenue	$614M	$594M	$573M	$665M	$555M	$514M	$389M	$781M	$632M	$527M	$560M	$553M	$483M	$422M	$519M	$688M	$593M	$219M	$526M	$743M	$607M
Gross Profit	$270M	$270M	$255M	$233M	$231M	$215M	$145M	$292M	$227M	$186M	$187M	$181M	$168M	$134M	$171M	$223M	$166M	($6M)	$127M	$220M	$187M
Gross Margin %	44.0%	45.5%	44.4%	35.1%	41.5%	41.8%	37.3%	37.4%	35.9%	35.2%	33.4%	32.8%	34.7%	31.8%	33.0%	32.4%	28.0%	-2.7%	24.1%	29.5%	30.7%
Operating Income (EBIT)	($21M)	($11M)	($30M)	($82M)	($24M)	$4M	($28M)	$55M	$34M	$18M	$19M	$22M	$4M	($8M)	$21M	$81M	$50M	($129M)	($27M)	$53M	$24M
Operating Margin %	-3.5%	-1.9%	-5.2%	-12.4%	-4.3%	0.7%	-7.1%	7.1%	5.5%	3.4%	3.5%	4.0%	0.8%	-2.0%	4.1%	11.7%	8.3%	-58.9%	-5.1%	7.1%	3.9%
Net Income	($123M)	($56M)	($165M)	($14M)	($429M)	$111M	$65M	$29M	$117M	$63M	($69M)	$14M	$4M	($2M)	$137M	$128M	$59M	($228M)	($237M)	$68M	$26M
Net Margin %	-20.0%	-9.4%	-28.8%	-2.1%	-77.2%	21.6%	16.7%	3.7%	18.5%	11.9%	-12.4%	2.6%	0.9%	-0.5%	26.3%	18.6%	10.0%	-104.2%	-45.0%	9.1%	4.3%
EBITDA	($97M)	$54M	$72M	$55M	$48M	$10M	$28M	$86M	$67M	$42M	$32M	$43M	$22M	$10M	$33M	$145M	$75M	($201M)	($201M)	$89M	$65M
Earnings Per Share (EPS)	$-2.67	$-1.21	$-3.10	$-0.22	$-5.73	$1.49	$0.88	$0.40	$1.64	$0.89	$-1.01	$0.21	$0.07	$-0.03	$2.08	$1.97	$0.92	$-3.62	$-3.67	$0.91	$0.36
Shares Outstanding (M)	45M	46M	53M	66M	75M	74M	74M	72M	71M	70M	69M	69M	68M	66M	66M	65M	64M	63M	65M	74M	73M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AZTA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$161M	$145M	$149M	$159M	$144M	$143M	$147M	$151M
Gross Profit	$72M	$62M	$64M	$72M	$68M	$66M	$69M	$68M
Gross Margin %	44.9%	42.8%	42.9%	45.4%	47.1%	45.9%	46.7%	45.5%
Operating Income (EBIT)	($4M)	($15M)	($5M)	$3M	$2M	($7M)	($4M)	$6M
Operating Margin %	-2.6%	-10.6%	-3.3%	1.8%	1.1%	-5.1%	-2.5%	4.0%
Net Income	$2M	($161M)	($15M)	$51M	($53M)	($40M)	($11M)	($7M)
Net Margin %	1.5%	-111.1%	-10.4%	32.0%	-36.7%	-28.2%	-7.5%	-4.4%
EBITDA	$14M	($143M)	$12M	$21M	$18M	$3M	$11M	$24M
Earnings Per Share (EPS)	$0.05	$-3.49	$-0.34	$1.11	$-1.16	$-0.88	$-0.24	$-0.13
Shares Outstanding (M)	45M	46M	46M	46M	46M	46M	46M	49M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AZTA Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Cash from Operations (CFO)	$38M	$72M	$50M	$6M	($466M)	$150M	$38M	$91M	$74M	$96M	$40M	$44M	$54M	$54M	$36M	$88M	$28M	($56M)	$14M	$73M	$65M
Capital Expenditures (CapEx)	$28M	$34M	$37M	$39M	$77M	$53M	$40M	$24M	$13M	$13M	$13M	$16M	$6M	$4M	$9M	$6M	$4M	$11M	$24M	$21M	$21M
Free Cash Flow (FCF)	$10M	$38M	$12M	($34M)	($543M)	$97M	($2M)	$67M	$61M	$83M	$27M	$28M	$48M	$51M	$27M	$81M	$24M	($68M)	($10M)	$52M	$44M
FCF Margin %	1.6%	6.5%	2.1%	-5.1%	-97.8%	18.9%	-0.5%	8.6%	9.7%	15.8%	4.8%	5.0%	10.0%	12.0%	5.3%	11.8%	4.0%	-31.0%	-1.9%	7.0%	7.3%
Dividends Paid	—	—	$0M	$0M	$7M	$30M	$30M	$29M	$28M	$28M	$28M	$27M	$23M	$21M	$21M	$5M	—	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AZTA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$3M	$12M	$21M	$2M	$26M	$14M	$30M	$14M
Capital Expenditures (CapEx)	$7M	$7M	$6M	$8M	$11M	$7M	$8M	$12M
Free Cash Flow (FCF)	($4M)	$5M	$15M	($6M)	$15M	$7M	$22M	$2M
FCF Margin %	-2.4%	3.3%	9.9%	-3.6%	10.4%	4.9%	14.9%	1.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AZTA Balance Sheet History

Balance sheet	2026-06-30	2025-09-30	2024-09-30	2023-09-30	2022-09-30	2021-09-30	2020-09-30	2019-09-30	2018-09-30	2017-09-30	2016-09-30	2015-09-30	2014-09-30	2013-09-30	2012-09-30	2011-09-30	2010-09-30	2009-09-30	2008-09-30	2007-09-30	2006-09-30
Total Assets	$1.9B	$2.1B	$2.1B	$2.9B	$3.7B	$1.8B	$1.6B	$1.5B	$1.1B	$767M	$686M	$760M	$778M	$737M	$742M	$637M	$518M	$413M	$664M	$1.0B	$993M
Cash & Cash Equivalents	$190M	$280M	$311M	$679M	$658M	$227M	$296M	$302M	$198M	$102M	$85M	$81M	$94M	$83M	$55M	$59M	$60M	$60M	$110M	$168M	$116M
Total Liabilities	$366M	$331M	$331M	$351M	$353M	$494M	$346M	$378M	$378M	$159M	$132M	$128M	$135M	$104M	$93M	$118M	$129M	$94M	$121M	$155M	$193M
Total Debt (Short + Long-Term)	$0M	$8M	$11M	$10M	$7M	$198M	$50M	$51M	$196M	$11M	$8M	$6M	$1M	$1M	$2M	$4M	$1M	$3M	$0M	$0M	$0M
Total Shareholders' Equity	$1.5B	$1.7B	$1.8B	$2.5B	$3.4B	$1.3B	$1.2B	$1.1B	$718M	$608M	$554M	$632M	$643M	$632M	$649M	$518M	$389M	$319M	$542M	$860M	$799M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AZTA viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

ATRC · AtriCure Inc — $3 billion
XRAY · Dentsply Sirona Inc — $2 billion
LMAT · LeMaitre Vascular Inc — $2 billion
BLFS · BioLife Solutions Inc — $2 billion
KMTS · Kestra Medical Technologies, Ltd. Common Stock — $1 billion
STAA · STAAR Surgical Company — $1 billion
MDLN · Medline Inc. Class A Common Stock — $43 billion
ALC · Alcon AG — $31 billion

← AZRT All “A” companies AZTD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.